Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company in transition. Investors are currently not well-favored towards Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) given the uncertainty looming over its drug pipeline and the consequences of the new strategy being implemented by its newly appointed CEO, but there is merit in the changes being carried out at this firm.